SABA, Vittorio
 Distribuzione geografica
Continente #
NA - Nord America 3.592
EU - Europa 1.791
AS - Asia 1.669
SA - Sud America 398
AF - Africa 101
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 7.556
Nazione #
US - Stati Uniti d'America 3.524
SG - Singapore 752
UA - Ucraina 396
BR - Brasile 325
CN - Cina 293
SE - Svezia 238
RU - Federazione Russa 201
DE - Germania 198
IE - Irlanda 197
TR - Turchia 196
DK - Danimarca 151
HK - Hong Kong 140
VN - Vietnam 134
IT - Italia 131
FI - Finlandia 106
KR - Corea 80
FR - Francia 68
CI - Costa d'Avorio 61
GB - Regno Unito 49
MX - Messico 32
AR - Argentina 30
CA - Canada 29
BD - Bangladesh 16
EC - Ecuador 14
MA - Marocco 14
PL - Polonia 14
ZA - Sudafrica 14
ID - Indonesia 13
IN - India 11
JP - Giappone 10
CL - Cile 8
CO - Colombia 8
RO - Romania 7
AT - Austria 6
BE - Belgio 6
IQ - Iraq 6
PY - Paraguay 6
BG - Bulgaria 4
LT - Lituania 4
NL - Olanda 4
AL - Albania 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
EG - Egitto 3
ES - Italia 3
IR - Iran 3
PE - Perù 3
PK - Pakistan 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
EU - Europa 2
NP - Nepal 2
OM - Oman 2
TN - Tunisia 2
UY - Uruguay 2
AO - Angola 1
AU - Australia 1
BB - Barbados 1
BO - Bolivia 1
CR - Costa Rica 1
CV - Capo Verde 1
CY - Cipro 1
DM - Dominica 1
EE - Estonia 1
IL - Israele 1
IS - Islanda 1
KE - Kenya 1
KZ - Kazakistan 1
LU - Lussemburgo 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
NZ - Nuova Zelanda 1
SA - Arabia Saudita 1
TO - Tonga 1
TT - Trinidad e Tobago 1
VE - Venezuela 1
Totale 7.556
Città #
Singapore 442
Jacksonville 396
Chandler 350
Ashburn 336
Dallas 263
Fairfield 251
Dublin 197
Boardman 183
Wilmington 143
Hong Kong 137
New York 120
Woodbridge 120
Seattle 111
Houston 105
Beijing 83
Lawrence 79
Princeton 79
San Mateo 79
Moscow 74
Ann Arbor 69
Cambridge 69
Abidjan 61
Hefei 57
Ho Chi Minh City 57
Los Angeles 48
Turin 44
Buffalo 35
São Paulo 35
Munich 29
Hanoi 26
Des Moines 20
San Diego 20
The Dalles 20
Turku 19
London 14
Mexico City 14
Warsaw 13
Chicago 12
Denver 12
Montreal 12
Shanghai 11
Atlanta 10
Brasília 10
Izmir 10
Santa Clara 10
Tokyo 10
Wuhan 10
Stockholm 9
Guangzhou 8
Helsinki 8
Johannesburg 8
Phoenix 8
Rio de Janeiro 8
Biên Hòa 7
Columbus 7
Falls Church 7
Belo Horizonte 6
Guayaquil 6
Haiphong 6
Jakarta 6
Norwalk 6
Nuremberg 6
Orem 6
Poplar 6
Aracaju 5
Brooklyn 5
Brussels 5
Can Tho 5
Da Nang 5
Dhaka 5
Kazan' 5
Kilburn 5
Maceió 5
Quận Bình Thạnh 5
Boston 4
Buenos Aires 4
Canoas 4
Chennai 4
Curitiba 4
Duque de Caxias 4
Manchester 4
Maricá 4
Ottawa 4
Palermo 4
Paris 4
Querétaro 4
San Jose 4
Venice 4
Wuxi 4
Augusta 3
Campinas 3
Campobasso 3
Cape Town 3
Caxias do Sul 3
Charlotte 3
Contagem 3
Detroit 3
Goiânia 3
Guarulhos 3
Jiaxing 3
Totale 4.566
Nome #
Prophylactic efficacy of topical temporin A and RNAIII-inhibiting peptide in a subcutaneous rat pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopeptides 233
RNAIII-inhibiting peptide in combination with the cathelicidin BMAP-28 reduces lethality in mouse models of staphylococcal sepsis 204
Citropin 1.1-treated central venous catheters improve the efficacy of hydrophobic antibiotics in the treatment of experimental staphylococcal catheter-related infection. 176
BisEDT and RIP act in synergy to prevent graft infections by resistant staphylococci. 175
Administration of protegrin peptide IB-367 to prevent endotoxin induced mortality in bile duct ligated rats. 132
Cecropin B enhances betalactams activities in experimental rat models of gram-negative septic shock 131
Attività ed espressione della ossido-nitrico sintetasi nella vescica di ratti sottoposti a neuromodulazione sacrale 129
Antiendotoxin activity of antimicrobial peptides and glycopeptides. 122
Amphibian Peptides Prevent Endotoxemia and Bacterial Translocation in Bile Duct-Ligated Rats 121
Therapeutic efficacy of intraperitoneal polymyxin B and polymyxin-like peptides alone or combined with levofloxacin in rat models of septic shock 121
Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus. 120
Cathelicidin peptide sheep myeloid antimicrobial peptide-29 prevents endotoxin-induced mortality in rat models of septic shock 117
Antiendotoxin activity of protegrin analog IB-367 alone or in combination with piperacillin in different animal models of septic shock 111
The antimicrobial peptide BMAP-28 reduces lethality in mouse models of staphylococcal sepsis 109
Activity and expression of nitric oxide synthase in rat bladder after sacral neuromodulation 108
Antiseptic compounds still active against bacterial strains isolated from surgical wound infections despite increasing antibiotic resistance. 108
A chimeric peptide composed of a dermaseptin derivative and an RNA III-inhibiting peptide prevents graft-associated infections by antibiotic-resistant staphylococci. 106
Efficacy of tachyplesin III, colistin, and imipenem against a multiresistant Pseudomonas aeruginosa strain. 104
Cationic peptides combined with betalactams reduce mortality from peritonitis in experimental rat model. 104
Mupirocin prophylaxis against methicillin-susceptible, methicillin-resistant, or vancomycin-intermediate Staphylococcus epidermidis vascular-graft infection. 103
Temporin A alone and in combination with imipenem reduces lethality in a mouse model of staphylococcal sepsis. 103
Interaction of antimicrobial peptide temporin L with lipopolysaccharide in vitro and in experimental rat models of septic shock caused by gram-negative bacteria. 102
Temporin A is effective in MRSA-infected wounds through bactericidal activity and acceleration of wound repair in a murine model. 102
Efficacy of quinupristin/dalfopristin in preventing vascular graft infection due to Staphylococcus epidermidis with intermediate resistance to glycopeptides. 100
Distinctin improves the efficacies of glycopeptides and betalactams against staphylococcal biofilm in an experimental model of central venous catheter infection. 99
Therapeutic efficacy of the magainin analogue MSI-78 in different intra-abdominal sepsis rat models. 98
LL-37 protects rats against lethal sepsis caused by gram-negative bacteria. 97
Comparative efficacy of quinupristin/dalfopristin, linezolid, vancomycin and ciprofloxacin in the treatment of experimental catheter-related infection due to Staphylococcus aureus using the antibiotic-lock technique 95
Suppression of drug-resistant Staphylococcal Infections by the quorum-sensing inhibitor RNAIII-inhibiting peptide. 95
RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections. 95
Temporin A soaking in combination with intraperitoneal linezolid prevents vascular graft infection in a subcutaneous rat pouch model of infection with Staphylococcus epidermidis with intermediate resistance to glycopeptides. 95
Single-dose intraperitoneal magainins improve survival in a gram-negative-pathogen septic shock rat model. 95
[Vascular graft infection by Staphylococcus epidermidis: efficacy of various perioperative prophylaxis protocols in an animal model]. 94
Effects of the antimicrobial peptide BMAP-27 in a mouse model of obstructive jaundice stimulated by lipopolysaccharide 94
Pre-treatment of central venous catheters with the cathelicidin BMAP-28 enhances the efficacy of antistaphylococcal agents in the treatment of experimental catheter-related infection. 93
Experimental study on the efficacy of combination of alpha-helical antimicrobial peptides and vancomycin against Staphylococcus aureus with intermediate resistance to glycopeptides. 93
RNAIII-Inhibiting Peptide-Loaded Polymethylmethacrylate Prevents In Vivo Staphylococcus aureus Biofilm Formation 92
Efficacy of colistin/rifampin combination in experimental rat models of sepsis due to a multiresistant Pseudomonas aeruginosa strain. 91
Protective effects of the combination of alpha-helical antimicrobial peptides and rifampicin in three rat models of Pseudomonas aeruginosa infection. 90
Effects of pexiganan alone and combined with betalactams in experimental endotoxic shock 89
Use of the quorum-sensing inhibitor RNAIII-inhibiting peptide to prevent biofilm formation in vivo by drug-resistant Staphylococcus epidermidis. 88
Prophylactic efficacy of linezolid alone or combined with levofloxacin and vancomycin in a rat subcutaneous pouch model of graft infection caused by Staphylococcus epidermidis with intermediate resistance to glycopeptides. 87
Effect of mono-dose intraperitoneal cecropins in experimental septic shock 87
LL-37 protects rats against lethal gram-negative sepsis. 86
Temporin A as a prophylactic agent against methicillin sodium-susceptible and methicillin sodium-resistant Staphylococcus epidermidis vascular graft infection. 85
RNA III inhibiting peptide inhibits in vivo biofilm formation by drug-resistant Staphylococcus aureus. 84
Treatment of Staphylococcus aureus Biofilm infection by the quorum sensing inhibitor RIP 83
Pretreatment with the protegrin IB-367 affects Gram-positive biofilm and enhances the therapeutic efficacy of linezolid in animal models of central venous catheter infection. 83
Polycationic peptides as prophylactic agents against methicillin-susceptible and methicillin-resistant Staphylococcus epidermidis vascular graft infection 83
Glyoxalase II and glutathione levels in rat liver mitochondria during cold storage in Euro-Collins and University of Wisconsin solutions 82
The lipopeptides Pal-Lys-Lys-NH(2) and Pal-Lys-Lys soaking alone and in combination with intraperitoneal vancomycin prevent vascular graft biofilm in a subcutaneous rat pouch model of staphylococcal infection 81
Potential therapeutic role of histatin derivative P-113d in experimental rat models of Pseudomonas aeruginosa sepsis. 80
RNAIII-inhibiting peptide and/or nisin inhibit experimental vascular graft infection with methicillin-susceptible and methicillin-resistant Staphylococcus epidermidis. 80
Neutralization of endotoxin in vitro and in vivo by Bac7(1-35), a proline-rich antibacterial peptide 78
Therapeutic efficacy of the polymyxin-like peptide ranalexin in an experimental model of endotoxemia. 77
RNAIII-inhibiting peptide improves efficacy of clinically used antibiotics in a murine model of staphylococcal sepsis. 77
Prophylaxis against Staphylococcus aureus vascular graft infection with mupirocin-soaked, collagen-sealed dacron. 77
1267 HSP70-2 polymorphism as a risk factor for carotid plaque rupture and cerebral ischaemia in old type 2 diabetes-atherosclerotic patients 76
Efficacy of rifampin-levofloxacin as a prophylactic agent in preventing Staphylococcus epidermidis graft infection. 75
Mupirocin as prophylactic agent against methicillin-susceptible, methicillin-resistant, and vancomycin-intermediate Staphylococcus epidermidis vascular graft infection. 73
Potential therapeutic role of cationic peptides in three experimental models of septic shock 72
The bovine antimicrobial peptide BMAP-28 reduces lethality due to bacterial cell wall components in mouse models of staphylococcal sepsis 72
Efficacy of polycationic peptides in preventing vascular graft infection due to Staphylococcus epidermidis. 72
Polycationic peptides as prophylactic agents against methicillin-susceptible or methicillin-resistant Staphylococcus epidermidis vascular graft infection. 72
Efficacy of colistin/rifampin combination in experimental rat models of sepsis due to multiresistant Pseudomonas aeruginosa strain 71
Efficacy of Tachyplesin III, Colistin and Imipenem against Multiresistant Pseudomonas aeruginosa 71
Temporin A Soaking in Combination with Intraperitoneal Linezolid Prevents Vascular Graft Infection in a Subcutaneous Rat Pouch Model Infected with Staphylococcus epidermidis with Intermediate Resistance to Glycopeptides 70
Prophylactic efficacy of linezolid alone or combined with levofloxacin and vancomycin in a rat subcutaneous pouch model of graft infection due to Staphylococcus epidermidis with intermediate resistance to glycopeptides 69
Potential therapeutic role of histatins derivative P-113D in experimental rat models of Pseudomonas sepsis 68
The cathelicidin-derived tritrpticin enhances the efficacy of ertapenem in experimental rat models of septic shock 67
Therapeutic efficacy of the magainin analog MSI-78 in different intra-abdominal sepsis rat models 66
Quinupristin/dalfopristin bonding in combination with intraperitoneal antibiotics prevent infection of knitted polyester graft material in a subcutaneous rat pouch model infected with resistant Staphylococcus epidermidis. 66
Single-dose intraperitoneal magainins improve survival in a gram-negative pathogens septic shock rat model. 65
Valore prognostico dell'indice Apache II nell'impiego routinario preoperatorio in chirurgia generale maggiore 65
Temporin A as prophylactic agent against methicillin-susceptible and methicillin-resistant Staphylococcus epidermidis vascular graft infection. 64
Interaction of antimicrobial peptide temporin L with lipopolisaccharide in vitro and in experimental rat models of Gram-negative septic shock. 62
RNAIII-inhibiting peptide improves efficacy of clinically used antibiotics in a murine models of staphylococcal sepsis 62
RNA III Inhibiting Peptide (RIP) inhibits in vivo biofilm formation by drug-resistant Staphylococcus aureus 61
RNAIII inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated S. aureus infections 60
Temporin A alone and in combination with imipenem reduces lethality in mouse models of staphylococcal sepsis 59
A novel Zip2 Gln/Arg/Leu codon 2 polymorphism is associated with carotid artery disease in aging 54
CD14 C (-260)T polymorphism, atherosclerosis, elderly: Role of cytokines and metallothioneins 39
Novel -209A/G MT2A polymorphism in old patients with type 2 diabetes and atherosclerosis: Relationship with inflammation (IL-6) and zinc 25
The +838 C/G MT2A polymorphism, metals, and the inflammatory/immune response in carotid artery stenosis in elderly people 25
Totale 7.645
Categoria #
all - tutte 36.184
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.184


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021624 0 0 0 0 0 88 104 74 114 91 104 49
2021/2022583 51 122 0 27 3 54 15 30 35 92 24 130
2022/20231.040 106 114 91 81 91 106 0 50 286 7 84 24
2023/2024518 109 12 22 88 89 122 5 5 3 4 13 46
2024/20251.462 171 100 93 82 63 95 163 69 260 55 140 171
2025/20261.767 210 371 329 425 371 61 0 0 0 0 0 0
Totale 7.645